Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00770458 · ClinicalTrials.gov registry record
Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
A clinical trial, sponsored by Sequenom.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT00770458: Completed study, sponsored by Sequenom.
NCT00770458 is a clinical trial that has completed, run by Sequenom. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00770458 has completed, sponsored by Sequenom.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
Validate that circulating cell free fetal nucleic acid can be used to identify a direct marker for fetal aneuploidy, particularly fetal Down Syndrome (DS), that is better than surrogate markers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2008-06 |
| Est. Completion | 2009-12 |
What the finished NCT00770458 record still lists
NCT00770458 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00770458 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00770458 about?
NCT00770458 is a clinical study titled "Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker". Validate that circulating cell free fetal nucleic acid can be used to identify a direct marker for fetal aneuploidy, particularly fetal Down Syndrome (DS), that is better than surrogate markers.
What is the current status of trial NCT00770458?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2008-06. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00770458?
This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia